共 12 条
- [1] A DOUBLE-BLIND TRIAL COMPARING ANTIEMETIC EFFICACY AND TOXICITY OF METOCLOPRAMIDE VERSUS METHYLPREDNISOLONE VERSUS DOMPERIDONE IN PATIENTS RECEIVING DOXORUBICIN CHEMOTHERAPY ALONE OR IN COMBINATION WITH OTHER ANTIBLASTIC AGENTS [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1988, 11 (05): : 594 - 596
- [3] ON THE RECEIVING END PATIENT PERCEPTION OF THE SIDE-EFFECTS OF CANCER-CHEMOTHERAPY [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02): : 203 - 208
- [6] DAVID M, 1984, CANCER TREAT REP, V68, P921
- [7] HAIT WN, 1990, NEW ENGL J MED, V323, P1485
- [10] PROTECTION FROM NAUSEA AND VOMITING IN CISPLATIN-TREATED PATIENTS - HIGH-DOSE METOCLOPRAMIDE COMBINED WITH METHYLPREDNISOLONE VERSUS METOCLOPRAMIDE COMBINED WITH DEXAMETHASONE AND DIPHENHYDRAMINE - A STUDY OF THE ITALIAN ONCOLOGY GROUP FOR CLINICAL RESEARCHR [J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (11) : 1693 - 1700